Martin Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Martin Capital Partners's GILD Position: Q1 2024 in Review
Martin Capital Partners sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 41,064 shares — an estimated $3.33M sold.
Martin Capital Partners first reported a position in GILD in Q3 2019 and held it in 18 quarters. The position peaked at $5.77M in Q4 2022. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Martin Capital Partners reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Martin Capital Partners sold 41,064 Gilead Sciences shares in Q1 2024, an estimated $3.33M.
- Martin Capital Partners first reported a position in Gilead Sciences in Q3 2019 and held it in 18 quarters.
- Martin Capital Partners's Gilead Sciences position peaked at $5.77M in Q4 2022.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Martin Capital Partners's 13F filing for Q1 2024, filed 5 Apr 2024.